Literature DB >> 446696

Experimental ischemic heart disease--effects of synthetic thromboxane A2.

S Morooka, M Kobayashi, T Takahashi, Y Takashima, M Sakamoto, T Shimamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 446696     DOI： 10.1016/0014-4800(79)90096-0

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN： 0014-4800            Impact factor:   3.362


× No keyword cloud information.
  4 in total

1.  AH23848, a thromboxane antagonist, suppresses ischaemia and reperfusion-induced arrhythmias in anaesthetized greyhounds.

Authors:  S J Coker; J R Parratt
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

2.  Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analogues.

Authors:  S E Burke; A M Lefer; K C Nicolaou; G M Smith; J B Smith
Journal:  Br J Pharmacol       Date:  1983-02       Impact factor: 8.739

3.  Lack of thromboxane A2 involvement in the arrhythmias occurring during acute myocardial ischemia in dogs.

Authors:  S E Burke; M J Antonaccio; A M Lefer
Journal:  Basic Res Cardiol       Date:  1982 Jul-Aug       Impact factor: 17.165

4.  Salutary actions of thromboxane synthetase inhibition during global myocardial ischemia.

Authors:  A M Lefer; M Messenger; S Okamatsu
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.